𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism

✍ Scribed by Mariarosaria Napolitano; Alessandro Giuliani; Tonino Alonzi; Carmine Mancone; Gianpiero D'Offizi; Marco Tripodi; Elena Bravo


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
113 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Several abnormalities of lipid metabolism, including hypo‐β‐lipoproteinemia and liver steatosis are associated with infection by hepatitis C virus (HCV). The aim of this study was to determine whether circulating lipoproteins of patients with HCV infection could directly cause alterations of lipid cellular metabolism. To this end the metabolic response of human monocyte‐derived macrophages (HMDM) to very low‐density lipoprotein (VLDL) and low‐density lipoprotein (LDL), measuring the cholesteryl ester (CE) and triglyceride (TG) production was analyzed. Lipoproteins were isolated from 18 patients infected with hepatitis C virus (HCV‐VLDL and HCV‐LDL) and from normal healthy donors (ct‐VLDL and ct‐LDL). In comparison to ct‐lipoproteins, HCV‐lipoproteins induced significant differences in HMDM CE and TG production. HCV‐VLDL decreased CE and TG production; while HCV‐LDL induced an increased TG synthesis. The present findings suggest that HCV infection modifies VLDL and LDL molecular composition, affecting cellular lipid metabolism, thus promoting intracellular lipid accumulation and hypo‐β‐lipoproteinemia. J. Med. Virol. 79:254–258, 2007. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Interferon-lambda genotype and low serum
✍ Josephine H. Li; Xiang Qian Lao; Hans L. Tillmann; Jennifer Rowell; Keyur Patel; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Recently, genetic polymorphisms occurring in the interferon (IFN)-lambda gene region were associated with response to IFN-based treatment of hepatitis C infection. Both infection with the hepatitis C virus and IFN therapy are associated with decreased serum cholesterol and high cholesterol has been